PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
35.71
+0.71 (2.03%)
At close: Dec 10, 2025, 4:00 PM EST
35.33
-0.38 (-1.06%)
After-hours: Dec 10, 2025, 7:37 PM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 7 analysts that cover PROCEPT BioRobotics stock have a consensus rating of "Buy" and an average price target of $50, which forecasts a 40.02% increase in the stock price over the next year. The lowest target is $38 and the highest is $60.
Price Target: $50 (+40.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 2 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $55 → $38 | Strong Buy → Hold | Downgrades | $55 → $38 | +6.41% | Dec 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $51 | Buy | Maintains | $56 → $51 | +42.82% | Dec 2, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $85 → $50 | Strong Buy | Maintains | $85 → $50 | +40.02% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $55 → $50 | Buy | Reiterates | $55 → $50 | +40.02% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $58 → $51 | Buy | Maintains | $58 → $51 | +42.82% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
333.01M
from 224.50M
Increased by 48.34%
Revenue Next Year
430.76M
from 333.01M
Increased by 29.35%
EPS This Year
-1.54
from -1.75
EPS Next Year
-1.17
from -1.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 355.4M | 454.7M | ||||
| Avg | 333.0M | 430.8M | ||||
| Low | 318.0M | 406.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 58.3% | 36.5% | ||||
| Avg | 48.3% | 29.4% | ||||
| Low | 41.6% | 22.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.54 | -0.55 | ||||
| Avg | -1.54 | -1.17 | ||||
| Low | -1.51 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.